Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
Recruiting · NCT06997094 · Registry updated 2026-07-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer | HPV-Negative Squamous Cell Carcinoma; Human Papillomavirus-Negative Neck Squamous Cell Carcinoma; Resectable Head and Neck Squamous Cell Carcinoma; Resectable Head and Neck Squamous-cell Carcinoma; Resectable Human Papillomavirus-Independent Head and Neck Mucosal Squamous Cell Carcinoma | Recruiting | Phase 1 | 2026-07-15 | NCT06997094 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic in Florida | Jacksonville | United States | 224 |